Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Caltrate with Vitamin D
Active Ingredients: Calcium carbonate 1.499g equivalent to calcium 600mg
Cholecalciferol 5µg equivalent to cholecalciferol 5µg (200IU)
Dosage Form: Tablet
New Zealand Sponsor: Wyeth Consumer Healthcare A Division of Wyeth (NZ) Limited
Manufacturer: Wyeth Pharmaceutical Co Limited, Suzhou, Jiangsu, China
Product: Hyalgan
Active Ingredient: Sodium hyaluronate 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Fidia Farmaceutici SpA, Abano Terme, Padova, Italy
Product: LoraPaed Oral Liquid
Active Ingredient: Loratadine 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland
Dated this 10th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).